Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Cyclerion Therapeutics, Inc. (CYCN)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cyclerion Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Cyclerion Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is CYCN. The reporting company's CIK number is 1755237.
The total value of stock buying since 2005 is $24,263,528.
The total value of stock sales since 2005 is $8,040.
The total value of stock option exercises since 2005 is $12,080.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-15||Busch Andreas (Chief Innovation Officer)||Buy||125,000||1.82||227,500|
|2019-11-08||Huyett William (Chief Financial Officer)||Sale||3,922||2.05||8,040|
|2019-07-10||Hecht Peter M (Chief Executive Officer)||Option Ex||2,000||6.04||12,080|
|2019-04-08||Schulman Amy W (Director)||Buy||626,117||16.00||10,017,872|
|2019-04-08||Mcguire Terrance (Director)||Buy||626,117||16.00||10,017,872|
|2019-04-02||Currie Mark G (President)||Buy||270,107||14.81||4,000,284|
Insider trading activities including stock purchases, stock sales, and option exercises of CYCN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cyclerion Therapeutics, Inc. (symbol CYCN, CIK number 1755237) see the Securities and Exchange Commission (SEC) website.